Jean Liew MD MS

Assistant Professor, Rheumatology

650 Albany St | (617) 358-9655
Jean Liew
Sections

Rheumatology

Centers

Arthritis & Autoimmune Diseases Research Center

Biography

Dr. Jean Liew graduated from the University of Texas at Austin with degrees in Biology and English and went on to earn her MD at the University of Texas Medical Branch in Galveston, TX. She then relocated to the Pacific Northwest to complete an Internal Medicine residency at Oregon Health & Science University in Portland, OR followed by rheumatology fellowship at the University of Washington in Seattle, WA. She concurrently earned an M.S. in Epidemiology through the University of Washington School of Public Health. During her fellowship, the primary focus of her research was in axial spondyloarthritis (axSpA), specifically AS, and cardiovascular comorbidity.

She is currently an Assistant Professor of Medicine in the Section of Rheumatology at BU, where her clinical research currently focuses on knee osteoarthritis and axSpA. Additionally, as a member of the COVID-19 Global Rheumatology Alliance (GRA) and a member of its Steering Committee, she has led multiple projects relating to data collection, analysis, and dissemination of the impact of the COVID-19 pandemic on individuals with rheumatic disease.

Education

MD, University of Texas Medical Branch

Epidemiology, MS, University of Washington

English, BA, University of Texas at Austin

Biology, BS, University of Texas at Austin

Publications

Published on 4/1/2025

Ferrandiz-Espadin R, Rabasa G, Gasman S, McGinley B, Stovall R, Jafarzadeh SR, Liew JW, Dubreuil M. Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis. J Rheumatol. 2025 Apr 01; 52(4):344-351. PMID: 39486857.

Published on 2/12/2025

Sendaydiego X, Gold LS, Dubreuil M, Andrews JS, Reid P, Liew DFL, Goulabchand R, Hughes GC, Sparks JA, Jarvik JG, Singh S, Liew JW, Singh N. Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2025 Feb 12. PMID: 39936579.

Published on 1/31/2025

King LK, Liew JW, Mahmoudian A, Wang Q, Jansen NEJ, Stanaitis I, Hung V, Berenbaum F, Das S, Ding C, Emery CA, Filbay SR, Hochberg MC, Ishijima M, Kloppenburg M, Lane NE, Losina E, Mobasheri A, Turkiewicz A, Runhaar J, Haugen IK, Appleton CT, Lohmander LS, Englund M, Neogi T, Hawker GA. Corrigendum to "Multi-centre modified Delphi exercise to identify candidate items for classifying early-stage symptomatic knee osteoarthritis" [Osteoarthritis Cartilage (2025) 155-165]. Osteoarthritis Cartilage. 2025 Apr; 33(4):530-533. PMID: 39890093.

Published on 1/23/2025

Crawford JM, Penberthy L, Pinto LA, Althoff KN, Assimon MM, Cohen O, Gillim L, Hammonds TL, Kapur S, Kaufman HW, Kwasny D, Liew JW, Meyer WA, Reynolds SL, Schleicher CB, Subbiah S, Theruviparampil C, Wallace ZS, Warner JL, Yoon S, Ziemba YC. Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions. Open Forum Infect Dis. 2025 Jan; 12(1):ofaf021. PMID: 39850579.

Published on 1/2/2025

Liew JW, Petrow E, Tilley S, LaValley MP, Roemer FW, Guermazi A, Lewis CE, Torner J, Nevitt MC, Lynch JA, Felson D. Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis Study. Ann Rheum Dis. 2025 Jan; 84(1):115-123. PMID: 39874225.

Published on 12/16/2024

Driscoll D, George N, Peloquin C, Jafarzadeh SR, Liew JW, Dubreuil M. Association of Therapies for Axial Spondyloarthritis on the Risk of Hip and Spine Fractures. Arthritis Rheumatol. 2024 Dec 16. PMID: 39679763.

Published on 11/28/2024

Naik A, Baraff A, Wysham KD, Liew JW, England BR, Roul P, George M, Baker JF, Barton JL, Makris UE, Kerr G, Cannon GW, Mikuls TR, Singh N. Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas. Arthritis Care Res (Hoboken). 2025 Jan; 77(1):23-29. PMID: 39467025.

Published on 11/8/2024

King LK, Liew JW, Mahmoudian A, Wang Q, Jansen NEJ, Stanaitis I, Hung V, Berenbaum F, Das S, Ding C, Emery CA, Filbay SR, Hochberg MC, Ishijima M, Kloppenburg M, Lane NE, Losina E, Mobasheri A, Turkiewicz A, Runhaar J, Haugen IK, Appleton CT, Lohmander LS, Englund M, Neogi T, Hawker GA. Multi-centre modified Delphi exercise to identify candidate items for classifying early-stage symptomatic knee osteoarthritis. Osteoarthritis Cartilage. 2025 Jan; 33(1):155-165. PMID: 39521366.

Published on 11/4/2024

Sendaydiego X, Gold LS, Dubreuil M, Andrews JS, Reid P, Liew DFL, Goulabchand R, Singh AG, Hughes GC, Pioro M, Sparks JA, Jarvik JG, Singh S, Liew JW, Singh N. Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk. JAMA Netw Open. 2024 Nov 04; 7(11):e2446336. PMID: 39565623.

Published on 10/3/2024

Liew JW, Petrow E, Tilley S, LaValley MP, Roemer FW, Guermazi A, Lewis CE, Torner J, Nevitt MC, Lynch JA, Felson D. Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis Study. Ann Rheum Dis. 2024 Oct 03. PMID: 39362696.

View full list of 119 publications.